Evidence map›Paper›PMID 22128182›Full record

ArticleThe Journal of biological chemistry2012

Plasmodium falciparum inhibitor-3 homolog increases protein phosphatase type 1 activity and is essential for parasitic survival.

Aline Fréville, Isabelle Landrieu, M Adelaida García-Gimeno, Jérôme Vicogne, Muriel Montbarbon, Benjamin Bertin, Alexis Verger, Hadidjatou Kalamou, Pascual Sanz, Elisabeth Werkmeister and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Characterization of the Regulatory AAA-ATPase Subunit Rpt3 inInternational journal of molecular sciences · 2025
    Article
  2. Open biology · 2022
    Article
  3. Review
  4. Article
  5. Article
  6. Identification of Three NovelFrontiers in cellular and infection microbiology · 2021
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 2 countries.

Aline FrévilleCenter for Infection and Immunity of Lille, Inserm U1019-CNRS UMR 8204, University of Lille Nord de France, Institut Pasteur de Lille, 1 Rue du Professeur Calmette, 59019 Lille Cedex, France.
Isabelle Landrieu
M Adelaida García-Gimeno
Jérôme Vicogne
Muriel Montbarbon
Benjamin Bertin
Alexis Verger
Hadidjatou Kalamou
Pascual Sanz
Elisabeth Werkmeister
Christine Pierrot
Jamal Khalife
Institut Pasteur de Lille · FRCentre National de la Recherche Scientifique · FRCenter for Infection and Immunity of Lille · FRCentre for Biomedical Network Research on Rare Diseases · ESInstitut de Biologie de Lille · FRInstituto de Biomedicina de Valencia · ESUnité de Glycobiologie Structurale et Fonctionnelle · FRUniversité de Lille · FRUniversité Lille Nord de France · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Growing evidence indicates that the protein regulators governing protein phosphatase 1 (PP1) activity have crucial functions because their deletion drastically affects cell growth and division. PP1 has been found to be essential in Plasmodium falciparum, but little is known about its regulators. In this study, we have identified a homolog of Inhibitor-3 of PP1, named PfI3. NMR analysis shows that PfI3 belongs to the disordered protein family. High affinity interaction of PfI3 and PfPP1 is demonstrated in vitro using several methods, with an apparent dissociation constant K(D) of 100 nm. We further show that the conserved (41)KVVRW(45) motif is crucial for this interaction as the replacement of the Trp(45) by an Ala(45) severely decreases the binding to PfPP1. Surprisingly, PfI3 was unable to rescue a yeast strain deficient in I3 (Ypi1). This lack of functional orthology was supported as functional assays in vitro have revealed that PfI3, unlike yeast I3 and human I3, increases PfPP1 activity. Reverse genetic approaches suggest an essential role of PfI3 in the growth and/or survival of blood stage parasites because attempts to obtain knock-out parasites were unsuccessful, although the locus of PfI3 is accessible. The main localization of a GFP-tagged PfI3 in the nucleus of all blood stage parasites is compatible with a regulatory role of PfI3 on the activity of nuclear PfPP1.

Indexed as

Cell NucleusEnzyme InhibitorsGenetic Complementation TestHumansIntracellular Signaling Peptides and ProteinsPlasmodium falciparumProtein BindingProtein Phosphatase 1Protozoan ProteinsSaccharomyces cerevisiaeEnzyme InhibitorsIntracellular Signaling Peptides and ProteinsProtein Phosphatase 1Protozoan Proteins

Identifiers

PMID22128182
PMCPMC3256872
OpenAlexW1972159625

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.